Global Diabetic Retinopathy Market Analysis By Type (Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR)), By Treatment (Anti-VEGF Injections, Corticosteroids, Laser Treatment, Surgery), By End User (Hospitals & Clinics, Ophthalmology Centers, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: April 2025
- Report ID: 145648
- Number of Pages: 397
- Format:
-
keyboard_arrow_up
-
-
- Novartis AG
- Bayer AG
- Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc.
- Carl Zeiss
- Optos
- Genentech Inc.
- AbbVie
- Eli Lilly and Company
- Viatris
- AstraZeneca
- Bausch Health Companies Inc.
Our Clients
- 145648
- April 2025
Trusted by more than 17382 organizations globally
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible
